This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Jan 6;139(1):1-2.

doi: 10.1182/blood.2021014046.

Eltrombopag: a springboard to early responses in SAA

Daria V Babushok^{1

2}

Affiliations

PMID: 34989776
DOI: 10.1182/blood.2021014046

Free article

Editorial

Eltrombopag: a springboard to early responses in SAA

Daria V Babushok. Blood. 2022.

Free article

. 2022 Jan 6;139(1):1-2.

doi: 10.1182/blood.2021014046.

Author

Daria V Babushok^{1

2}

Affiliations

¹ University of Pennsylvania and.
² Children's Hospital of Philadelphia.

PMID: 34989776
DOI: 10.1182/blood.2021014046

No abstract available

PubMed Disclaimer

Comment on

Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study.
Patel BA, Groarke EM, Lotter J, Shalhoub R, Gutierrez-Rodrigues F, Rios O, Quinones Raffo D, Wu CO, Young NS. Patel BA, et al. Blood. 2022 Jan 6;139(1):34-43. doi: 10.1182/blood.2021012130. Blood. 2022. PMID: 34525188 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

K08 HL132101/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems